论文部分内容阅读
目的:观察泛福舒对婴幼儿反复呼吸道感染的治疗作用。方法:选取反复呼吸道感染患儿130例,采用随机数字表法分为治疗组和对照组,每组各65例。对照组以抗感染等常规治疗为主,治疗组在常规治疗基础上给予泛福舒胶囊治疗,比较两组治疗后总有效率、呼吸道感染次数、持续时间和抗生素使用时间,观察治疗前后IgA、IgM和IgG水平变化。结果:治疗组总有效率明显高于对照组(P<0.05)。治疗组患儿呼吸道感染次数、持续时间和抗生素使用时间明显低于对照组(P<0.05)。治疗组疗程结束后IgA和IgG水平有所升高,与治疗前相比,差异具有统计学意义,而IgM水平治疗前后无明显变化,差异无显著性(P>0.05)。对照组治疗前后IgA、IgM和IgG比较差异无统计学意义(P>0.05)。结论:泛福舒可能通过提高患儿机体免疫力,增强患儿体质,减少呼吸道感染发生,在门诊中可给予小儿预防性运用,达到防治呼吸道感染发生的目的。
Objective: To observe the therapeutic effect of Pan Fu Shu on recurrent respiratory tract infections in infants. Methods: A total of 130 children with recurrent respiratory tract infection were selected and randomly divided into treatment group and control group with 65 cases in each group. The control group was mainly treated with anti-infection and other conventional treatments. The treatment group was treated with Pan Fu Shu Capsule on the basis of routine treatment. The total effective rate, the number of respiratory infections, the duration of the respiratory tract infection and the antibiotic use time were compared between the two groups. The levels of IgA, IgM and IgG levels change. Results: The total effective rate in the treatment group was significantly higher than that in the control group (P <0.05). The number of respiratory tract infections, duration and duration of antibiotics in treatment group were significantly lower than those in control group (P <0.05). The levels of IgA and IgG in the treatment group increased after the treatment, which had statistical significance compared with those before treatment, while there was no significant difference in the levels of IgM before and after treatment (P> 0.05). There was no significant difference of IgA, IgM and IgG in the control group before and after treatment (P> 0.05). Conclusion: Pan Fu Shu may improve the immunity of children, enhance the physique of infants and reduce the occurrence of respiratory infections. In the outpatient department, prophylactic use may be given to prevent and cure respiratory infections.